A common antidepressant shows promise in reducing methamphetamine use in a large Australian trial. The study indicates that mirtazapine led to fewer days of meth use over 12 weeks compared with placebo, offering a potential pharmacological option in the absence of approved medications. The findings suggest a direct effect on brain reward pathways beyond mood improvement.

This topic is of interest to psychology readers because it explores how existing medications can influence addictive behaviors and brain reward systems, contributing to understanding treatment approaches for substance use disorders.

Article Title: A common antidepressant shows promise in treating methamphetamine dependence

Link to PsyPost Article: https://www.psypost dot org/a-common-antidepressant-shows-promise-in-treating-methamphetamine-dependence/

Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.

#methamphetamine #mirtazapine #substanceuse #psychopharmacology #addictiontreatment

RE: https://todon.nl/@prolrage/116357160186513402

🗨️ Doesn't surprise me, a society that's solely based on the idea that using #weapons is a perfectly normal right, even to shoot others on your own property, can't produce healthy #children!

It's a #society based on #violence, abuse of #humanrights and #xenophobia -

Also their #methamphetamine ab-usus has statistically surpassed #alcohol abuse (!), really bad for #US brains - not to mention #bingewatching of dull #TV series, #antidepressants, #oxycodone, mixed with mass-produced cheap #meat